ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS

QR Code

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS

Aim. To study the associations between genetic polymorphisms and the development of clopidogrel resistance in patients referred for percutaneous coronary interventions (PCI).Material and methods. The study included 84 patients with coronary heart disease (CHD), who underwent planned PCI. Dynamic ass...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. T. Matskeplishvili, E. B. Prokhorchuk, Ya. E. Arutyunova, I. V. Koksheneva, L. S. Shakhnazaryan, B. R. Sandukhadze, K. G. Skryabin, A. V. Melerzanov, Yu. I. Buziashvili
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	coronary heart disease percutaneous coronary interventions resistance polymorphism
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/208
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

predictors of long-term fatal cardiovascular events after planned percutaneous coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-12-01)

Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention
by: Yaxin Xiong, et al.
Published: (2025-06-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 1. EVIDENCE BASE FOR APPLYING A TRANSRADIAL APPROACH
by: Sh. T. Zhamgyrchiev, et al.
Published: (2016-06-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Yukinori Harada, et al.
Published: (2016-12-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Myocardial revascularization by percutaneous coronary intervention in senile patients with chronic total occlusion: a modern view of the problem
by: E. R. Atamanyuk, et al.
Published: (2022-02-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Percutaneous coronary interventions for ST elevation myocardial infarction in different age groups
by: I. S. Bessonov, et al.
Published: (2021-04-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Review of the arm alternative arterial access sites for percutaneous interventions
by: Ungureanu Claudiu, et al.
Published: (2025-06-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

A rare case of successful recanalization of the anterior interventricular artery through a mammary-coronary graft in a patient 15 years after coronary artery bypass grafting
by: M. A. Alekseeva, et al.
Published: (2018-12-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: O. O. Shakhmatova, et al.
Published: (2016-01-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 2. PRACTICAL GUIDELINES AND THE AUTHORS’ DATA
by: A. S. Tereshchenko, et al.
Published: (2016-02-01)

Outcomes of percutaneous coronary intervention in COVID-19-positive acute coronary syndrome patients: a retrospective study in Vietnam
by: Duy Cao Phuong Le, et al.
Published: (2025-07-01)

Restenosis pathophysiological mechanisms and genetic markers after percutaneous coronary interventions
by: Yu. A. Shuvalova, et al.
Published: (2007-10-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Distal radial access as an alternative to conventional radial access in coronary angiography and percutaneous coronary interventions
by: A. V. Korotkikh, et al.
Published: (2025-01-01)

Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
by: Sh. Sh. Zaynobidinov, et al.
Published: (2025-05-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

PHYSICAL TRAINING IN THE REHABILITATION AND PREVENTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PERCUTANEOUS CORONARY INTERVENTIONS: THE BORDERS OF EFFICIENCY AND SAFETY
by: N. P. Lyamina, et al.
Published: (2014-06-01)

LONG TERM RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS COMPARING WITH CONSERVATIVE MANAGEMENT IN TREATMENT OF STABLE ISCHEMIC HEART DISEASE PATIENTS UNDER REAL CIRCUMSTANCES
by: V. A. Kuznetsov, et al.
Published: (2016-02-01)

Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention
by: A. I. Abdrahmanova, et al.
Published: (2022-05-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease
by: T. A. Batyraliev, et al.
Published: (2011-08-01)

Impact of assessment of fractional flow reserve and instantaneous wave-free ratio on clinical outcomes of percutaneous coronary intervention: a systematic review, meta-analysis and meta-regression analysis
by: E. Z. Golukhova, et al.
Published: (2023-03-01)

Association of ACE gene polymorphisms with cardiovascular events in patients after elective percutaneous coronary interventions
by: E. O. Nalesnik, et al.
Published: (2022-11-01)